Korean J Crit Care Med.  2011 Jun;26(2):117-121. 10.4266/kjccm.2011.26.2.117.

Amiodarone-induced Pulmonary Toxicity within a Short Period of the Initiation of Amiodarone Therapy: A Case Report

Affiliations
  • 1Division of Cardiology, Department of Internal Medicine, Hanil General Hospital, Seoul, Korea. jimmy5058@hanmail.net
  • 2Division of Pulmonology, Department of Internal Medicine, Hanil General Hospital, Seoul, Korea.

Abstract

Amiodarone is one of the most commonly prescribed antiarrhythmic drug for almost all atrial or ventricular arrythmias. Amiodarone-induced pulmonary toxicity (APT) was first described in 1980 and has potentially serious side effects that are believed to develop in 5% of patients. In general, APT occurs only when high amiodarone doses are used for a long time. However, during short-term therapy of amiodarone, APT is rarely reported. In this report, we describe a case of amiodarone-induced pulmonary toxicity after a short course of amiodarone therapy for atrial fibrillation.

Keyword

amiodarone; pulmonary toxicity; short course of therapy

MeSH Terms

Amiodarone
Arrhythmias, Cardiac
Atrial Fibrillation
Dimaprit
Humans
Amiodarone
Dimaprit
Full Text Links
  • KJCCM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr